These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Intravitreal ranibizumab for choroidal neovascularisation associated with adult-onset vitelliform dystrophy]. Prieto-Calvo E, Torrón-Fernández Blanco C, Egea-Estopiñán C, Güerri-Monclús N, Ferrer-Novella E, Ruiz-Moreno O, Pablo-Julvez LE. Arch Soc Esp Oftalmol; 2012 May; 87(5):149-52. PubMed ID: 22554558 [Abstract] [Full Text] [Related]
4. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Rouvas A, Petrou P, Douvali M, Ntouraki A, Vergados I, Georgalas I, Markomichelakis N. Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461 [Abstract] [Full Text] [Related]
5. Functional and anatomic changes in bilateral choroidal neovascularization associated with vitelliform macular dystrophy after intravitreal bevacizumab. Cennamo G, Cesarano I, Vecchio EC, Reibaldi M, de Crecchio G. J Ocul Pharmacol Ther; 2012 Dec; 28(6):643-6. PubMed ID: 22742532 [Abstract] [Full Text] [Related]
6. Long-term outcomes of intravitreal ranibizumab for choroidal neovascularization secondary to Best's disease: 3-year follow-up. Ruiz-Moreno O, Calvo P, Ferrández B, Torrón C. Acta Ophthalmol; 2012 Nov; 90(7):e574-5. PubMed ID: 22339886 [No Abstract] [Full Text] [Related]
7. Lack of Response to Intravitreal Ranibizumab Treatment in Adult Onset Foveomacular Vitelliform Dystrophy Complicated with Choroidal Neovascularization: A Case Report. Berhuni M, Tıskaoğlu SN, Ozturkmen C. Cesk Slov Oftalmol; 2024 Nov; 80(Ahead of print):1-3. PubMed ID: 38925903 [Abstract] [Full Text] [Related]
8. Choroidal neovascularization associated with butterfly-shaped pattern dystrophy - a case report. Świerczyńska M, Danikiewicz-Zagała M, Sedlak L, Nowak-Wąs M, Wyględowska-Promieńska D. Rom J Ophthalmol; 2023 Nov; 67(2):185-190. PubMed ID: 37522013 [Abstract] [Full Text] [Related]
9. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections. Coscas F, Querques G, Forte R, Terrada C, Coscas G, Souied EH. Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476 [Abstract] [Full Text] [Related]
13. Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child. Chhablani J, Jalali S. Eur J Ophthalmol; 2012 Mar; 22(4):677-9. PubMed ID: 22139615 [Abstract] [Full Text] [Related]
14. [Intravitreal ranibizumab injection for the treatment of idiopathic choroidal neovascularisation in young patients]. Ouhadj O, Degheb N, Idir S, Nebab A, Nouri MT. J Fr Ophtalmol; 2012 Sep; 35(7):514-22. PubMed ID: 22789650 [Abstract] [Full Text] [Related]
15. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series. Iacono P, Parodi MB, Papayannis A, Kontadakis S, Sheth S, Bandello F. Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926 [Abstract] [Full Text] [Related]
17. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration]. Bidot ML, Malvitte L, Bidot S, Bron A, Creuzot-Garcher C. J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687 [Abstract] [Full Text] [Related]